Astra Zeneca gets nod for anticoagulant drug
Saturday, 20 January 2024
AstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organisation for the import and marketing of Andexanet Alfa. The therapy addresses life-threatening or refractory bleeding associated with the use of Factor Xa (FXa) inhibitors, says a company statement.FXa inhibitors are increasingly employed for preventing and treating thrombotic events, such as deep vein thrombosis and pulmonary embolism, as well as in patients at high risk of stroke due to atrial fibrillation. While these medications effectively prevent unwanted clot formation, they also elevate the risk of major bleeding, which can be life-threatening.
AstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organisation for the import and marketing of Andexanet Alfa. The therapy addresses life-threatening or refractory bleeding associated with the use of Factor Xa (FXa) inhibitors, says a company statement.FXa inhibitors are increasingly employed for preventing and treating thrombotic events, such as deep vein thrombosis and pulmonary embolism, as well as in patients at high risk of stroke due to atrial fibrillation. While these medications effectively prevent unwanted clot formation, they also elevate the risk of major bleeding, which can be life-threatening.
|
||||
|
||||
You Might Like💡 newsR Knowledge: Other News MentionsAstraZeneca British pharmaceutical companyDominica to honour PM for aid during pandemicIndian Prime Minister Narendra Modi is set to receive Dominica's highest civilian award, the Dominica Award of Honour. The award recognizes Modi's contributions..IndiaTimes Central Drugs Standard Control Organisation Indian Apex Drug Regulatory BodyBring health supplements under drug control watch, suggests panelAn inter-ministerial committee has recommended that health supplements claiming to cure or mitigate diseases be classified as drugs. This shift aims to increase..IndiaTimes Related news from verified sources
|